FDA Issues Draft Labeling Guidance on Indications and Usage

Drug Industry Daily
A A
The FDA released draft guidance outlining the information sponsors should include on the Indications and Usage section of drug and biologics labeling.

To View This Article:

Login

Subscribe To Drug Industry Daily